UIF, a New mRNA export adaptor that works together with REF/ALY, requires FACT for recruitment to mRNA. 2009

Guillaume M Hautbergue, and Ming-Lung Hung, and Matthew J Walsh, and Ambrosius P L Snijders, and Chung-Te Chang, and Rachel Jones, and Chris P Ponting, and Mark J Dickman, and Stuart A Wilson
Department of Molecular Biology and Biotechnology, The University of Sheffield, Western Bank, Sheffield, UK.

Messenger RNA (mRNA) export adaptors play an important role in the transport of mRNA from the nucleus to the cytoplasm. They couple early mRNA processing events such as 5' capping and 3' end formation with loading of the TAP/NXF1 export receptor onto mRNA. The canonical adaptor REF/ALY/Yra1 is recruited to mRNA via UAP56 and subsequently delivers the mRNA to NXF1 [1]. Knockdown of UAP56 [2, 3] and NXF1 [4-7] in higher eukaryotes efficiently blocks mRNA export, whereas knockdown of REF only causes a modest reduction, suggesting the existence of additional adaptors [8-10]. Here we identify a new UAP56-interacting factor, UIF, which functions as an export adaptor, binding NXF1 and delivering mRNA to the nuclear pore. REF and UIF are simultaneously found on the same mRNA molecules, and both proteins are required for efficient export of mRNA. We show that the histone chaperone FACT specifically binds UIF, but not REF, via the SSRP1 subunit, and this interaction is required for recruitment of UIF to mRNA. Together the results indicate that REF and UIF represent key human adaptors for the export of cellular mRNAs via the UAP56-NXF1 pathway.

UI MeSH Term Description Entries
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006657 Histones Small chromosomal proteins (approx 12-20 kD) possessing an open, unfolded structure and attached to the DNA in cell nuclei by ionic linkages. Classification into the various types (designated histone I, histone II, etc.) is based on the relative amounts of arginine and lysine in each. Histone,Histone H1,Histone H1(s),Histone H2a,Histone H2b,Histone H3,Histone H3.3,Histone H4,Histone H5,Histone H7
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001692 Biological Transport The movement of materials (including biochemical substances and drugs) through a biological system at the cellular level. The transport can be across cell membranes and epithelial layers. It also can occur within intracellular compartments and extracellular compartments. Transport, Biological,Biologic Transport,Transport, Biologic
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D014157 Transcription Factors Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process. Transcription Factor,Factor, Transcription,Factors, Transcription
D055785 Gene Knockdown Techniques The artificial induction of GENE SILENCING by the use of RNA INTERFERENCE to reduce the expression of a specific gene. It includes the use of DOUBLE-STRANDED RNA, such as SMALL INTERFERING RNA and RNA containing HAIRPIN LOOP SEQUENCE, and ANTI-SENSE OLIGONUCLEOTIDES. Gene Knock Down Techniques,Gene Knock Down,Gene Knock-Down,Gene Knock-Down Techniques,Gene Knockdown,Gene Knock Downs,Gene Knock-Down Technique,Gene Knock-Downs,Gene Knockdown Technique,Gene Knockdowns,Knock Down, Gene,Knock Downs, Gene,Knock-Down Technique, Gene,Knock-Down Techniques, Gene,Knock-Down, Gene,Knock-Downs, Gene,Knockdown Technique, Gene,Knockdown Techniques, Gene,Knockdown, Gene,Knockdowns, Gene,Technique, Gene Knock-Down,Technique, Gene Knockdown,Techniques, Gene Knock-Down,Techniques, Gene Knockdown
D018832 Molecular Chaperones A family of cellular proteins that mediate the correct assembly or disassembly of polypeptides and their associated ligands. Although they take part in the assembly process, molecular chaperones are not components of the final structures. Chaperones, Molecular,Chaperone, Molecular,Molecular Chaperone

Related Publications

Guillaume M Hautbergue, and Ming-Lung Hung, and Matthew J Walsh, and Ambrosius P L Snijders, and Chung-Te Chang, and Rachel Jones, and Chris P Ponting, and Mark J Dickman, and Stuart A Wilson
July 2013, Journal of virology,
Guillaume M Hautbergue, and Ming-Lung Hung, and Matthew J Walsh, and Ambrosius P L Snijders, and Chung-Te Chang, and Rachel Jones, and Chris P Ponting, and Mark J Dickman, and Stuart A Wilson
July 2003, RNA (New York, N.Y.),
Guillaume M Hautbergue, and Ming-Lung Hung, and Matthew J Walsh, and Ambrosius P L Snijders, and Chung-Te Chang, and Rachel Jones, and Chris P Ponting, and Mark J Dickman, and Stuart A Wilson
July 2011, PLoS pathogens,
Guillaume M Hautbergue, and Ming-Lung Hung, and Matthew J Walsh, and Ambrosius P L Snijders, and Chung-Te Chang, and Rachel Jones, and Chris P Ponting, and Mark J Dickman, and Stuart A Wilson
January 2008, Molecular and cellular biology,
Guillaume M Hautbergue, and Ming-Lung Hung, and Matthew J Walsh, and Ambrosius P L Snijders, and Chung-Te Chang, and Rachel Jones, and Chris P Ponting, and Mark J Dickman, and Stuart A Wilson
March 2009, The EMBO journal,
Guillaume M Hautbergue, and Ming-Lung Hung, and Matthew J Walsh, and Ambrosius P L Snijders, and Chung-Te Chang, and Rachel Jones, and Chris P Ponting, and Mark J Dickman, and Stuart A Wilson
June 2005, The FEBS journal,
Guillaume M Hautbergue, and Ming-Lung Hung, and Matthew J Walsh, and Ambrosius P L Snijders, and Chung-Te Chang, and Rachel Jones, and Chris P Ponting, and Mark J Dickman, and Stuart A Wilson
January 2013, PloS one,
Guillaume M Hautbergue, and Ming-Lung Hung, and Matthew J Walsh, and Ambrosius P L Snijders, and Chung-Te Chang, and Rachel Jones, and Chris P Ponting, and Mark J Dickman, and Stuart A Wilson
February 2024, Life sciences,
Guillaume M Hautbergue, and Ming-Lung Hung, and Matthew J Walsh, and Ambrosius P L Snijders, and Chung-Te Chang, and Rachel Jones, and Chris P Ponting, and Mark J Dickman, and Stuart A Wilson
July 2009, Journal of virology,
Guillaume M Hautbergue, and Ming-Lung Hung, and Matthew J Walsh, and Ambrosius P L Snijders, and Chung-Te Chang, and Rachel Jones, and Chris P Ponting, and Mark J Dickman, and Stuart A Wilson
December 2002, Journal of virology,
Copied contents to your clipboard!